Learn, Analyse & Invest
only with
only with
+91
Download Orca
Samrat Pharmachem Ltd.
Samrat Pharmachem
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹65.22 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 13 11 2021 | Quarterly Results |
| 10 02 2022 | Quarterly Results |
| 30 05 2022 | Dividend & Audited Results |
| 13 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 16 03 2023 | Inter alia, to consider and approve re-appointment of 3 Executive Directors of the company namely, Mr. Lalit Mehta, Chairman & Managing Director (DIN: 00216681), Mr. Rajesh Mehta, Executive Director (DIN: 00216731) & Mr. Megh Mehta, Executive Director (DIN: 07287394) for a further period of 3 years effective from April 1, 2023 to March 31, 2026, based on the recommendations of the Nomination & Remuneration Committee and to approve the re-appointment through the postal ballot. |
| 30 05 2023 | Dividend & Audited Results |
| 14 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 30 05 2024 | Final Dividend & Audited Results |
| 14 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 30 05 2025 | Final Dividend & Audited Results |
| 13 08 2025 | Quarterly Results |
| 14 11 2025 | Quarterly Results |
| 13 02 2026 | Quarterly Results |
| 30 05 2026 | Audited Results |
News
No News data available
